QY Research > レポート一覧 > 薬品及びサプリメント > ポリミキシン B 硫酸塩 APIの世界市場レポート2025-2031

ポリミキシン B 硫酸塩 APIの世界市場レポート2025-2031

英文タイトル: Global Polymyxin B Sulfate API Market Insights, Forecast to 2031

ポリミキシン B 硫酸塩 APIの世界市場レポート2025-2031
  • レポートID:397069
  • 発表時期:2025-07-08
  • 訪問回数:945
  • ページ数:147
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:146
  • レポートカテゴリ: 薬品及びサプリメント

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=148.50円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=148.50円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は、ポリミキシン B 硫酸塩 APIの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にポリミキシン B 硫酸塩 API市場を分類しています。

本レポートでは世界のポリミキシン B 硫酸塩 API市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:Xellia Pharmaceuticals Aps、Biotika As、Medisca、Hangzhou Zhongmei Huadong Pharmaceutical、Alp Pharm、Yancheng Youhua Pharmaceutical And Chemical Technology、Shandong Luxi Pharmaceutical、Jiangxi Nuclear Industry Reyphon Bio-Chemical、North China Pharmaceutical Huasheng、Ganzhou Ruizhi Pharmaceutical、ChemWerth、LGM Pharma、Rochem International

レポートはポリミキシン B 硫酸塩 APIの主要生産者を調査し、主要地域や国の消費状況も提供します。ポリミキシン B 硫酸塩 APIの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント:
Purity ≥99%
95%≤purity≤99%

用途別の市場セグメント:
Injection
Others

レポートの詳細内容
本レポートは、世界のポリミキシン B 硫酸塩 API市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてポリミキシン B 硫酸塩 API市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別(地域レベル、国レベル)のポリミキシン B 硫酸塩 API生産量、成長率、市場シェアを調査している。

二. 消費面では、ポリミキシン B 硫酸塩 APIの売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのポリミキシン B 硫酸塩 API売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のポリミキシン B 硫酸塩 API市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ポリミキシン B 硫酸塩 APIのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

1章:ポリミキシン B 硫酸塩 APIのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(20202031
2章: ポリミキシン B 硫酸塩 APIの世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(20202031
3章:世界、地域、国レベルにおけるポリミキシン B 硫酸塩 APIの売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(20202031
4ポリミキシン B 硫酸塩 APIメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(20202025
5章:ポリミキシン B 硫酸塩 APIの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20202031
6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(20202031
7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(20202031
8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(20202031
9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(20202031
10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(20202031
11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(20202031
12章:ポリミキシン B 硫酸塩 APIの主要メーカーの概要を提供し、製品の説明と仕様、ポリミキシン B 硫酸塩 APIの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(20202025
13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
14章:ポリミキシン B 硫酸塩 APIの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
15章:レポートの要点と結論。

biaoTi

概要

The global Polymyxin B Sulfate API market is projected to grow from US$ 204 million in 2025 to US$ 292 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.
Polymyxin B Sulfate Active Pharmaceutical Ingredient (API) refers to the active pharmaceutical ingredient used to produce polymyxin B sulfate preparations and is the core active substance in the preparation. Its chemical name is polymyxin B sulfate, which belongs to the polypeptide antibiotics. It is prepared by fermentation process or chemical synthesis and is ultimately used to prepare injections, powder injections and other dosage forms. Polymyxin B sulfate API is the basic substance for the production of drugs against multidrug-resistant Gram-negative bacteria, and its quality directly affects the safety and effectiveness of the preparation. Through strict process control and quality standards, its reliable application as a "last line of defense" antibiotic in clinical practice can be ensured.
The global increase in the infection rate of carbapenem-resistant Gram-negative bacteria (CRO), such as carbapenem-resistant Klebsiella pneumoniae (CRKP) and Pseudomonas aeruginosa (CRPA), has driven the demand for polymyxin B as a "last line of defense" antibiotic. The WHO lists polymyxins as core drugs for the treatment of multidrug-resistant bacterial infections, and the US IDSA guidelines also recommend their use in combination therapy. In addition, due to the abuse of antibiotics and differences in medical levels, the Asia-Pacific and Latin American regions have prominent problems with drug-resistant bacteria, making them the main regions for the growth of demand for polymyxin B sulfate API.
In terms of consumption side, this report focuses on the sales of Polymyxin B Sulfate API by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Polymyxin B Sulfate API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Polymyxin B Sulfate API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Polymyxin B Sulfate API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polymyxin B Sulfate API sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Polymyxin B Sulfate API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Polymyxin B Sulfate API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Xellia Pharmaceuticals Aps, Biotika As, Medisca, Hangzhou Zhongmei Huadong Pharmaceutical, Alp Pharm, Yancheng Youhua Pharmaceutical And Chemical Technology, Shandong Luxi Pharmaceutical, Jiangxi Nuclear Industry Reyphon Bio-Chemical, North China Pharmaceutical Huasheng, Ganzhou Ruizhi Pharmaceutical, etc.

Market Segmentation
By Company
    Xellia Pharmaceuticals Aps
    Biotika As
    Medisca
    Hangzhou Zhongmei Huadong Pharmaceutical
    Alp Pharm
    Yancheng Youhua Pharmaceutical And Chemical Technology
    Shandong Luxi Pharmaceutical
    Jiangxi Nuclear Industry Reyphon Bio-Chemical
    North China Pharmaceutical Huasheng
    Ganzhou Ruizhi Pharmaceutical
    ChemWerth
    LGM Pharma
    Rochem International

Segment by Type
    Purity ≥99%
    95%≤purity≤99%

Segment by Application
    Injection
    Others

Production by Region
    North America
    Europe
    China
    Japan

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Polymyxin B Sulfate API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Polymyxin B Sulfate API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polymyxin B Sulfate API sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
biaoTi

総目録

1 Study Coverage
1.1 Polymyxin B Sulfate API Product Introduction
1.2 Market by Type
1.2.1 Global Polymyxin B Sulfate API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
1.2.2 Purity ≥99%
1.2.3 95%≤purity≤99%
1.3 Market by Application
1.3.1 Global Polymyxin B Sulfate API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
1.3.2 Injection
1.3.3 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Polymyxin B Sulfate API Revenue Estimates and Forecasts 2020-2031
2.2 Global Revenue by Region
2.2.1 Global Polymyxin B Sulfate API Revenue by Region: 2020 VS 2024 VS 2031
2.2.2 Global Polymyxin B Sulfate API Revenue by Region (2020-2031)
2.2.3 Global Polymyxin B Sulfate API Revenue Market Share by Region (2020-2031)
2.3 Global Polymyxin B Sulfate API Sales Estimates and Forecasts 2020-2031
2.4 Global Sales by Region
2.4.1 Global Polymyxin B Sulfate API Sales by Region: 2020 VS 2024 VS 2031
2.4.2 Global Polymyxin B Sulfate API Sales by Region (2020-2031)
2.4.3 Global Polymyxin B Sulfate API Sales Market Share by Region (2020-2031)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers
3.1 Global Sales by Manufacturers
3.1.1 Global Polymyxin B Sulfate API Sales by Manufacturers (2020-2025)
3.1.2 Global Polymyxin B Sulfate API Sales Market Share by Manufacturers (2020-2025)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polymyxin B Sulfate API in 2024
3.2 Global Revenue by Manufacturers
3.2.1 Global Polymyxin B Sulfate API Revenue by Manufacturers (2020-2025)
3.2.2 Global Polymyxin B Sulfate API Revenue Market Share by Manufacturers (2020-2025)
3.2.3 Global Top 10 and Top 5 Companies by Polymyxin B Sulfate API Revenue in 2024
3.3 Global Key Players of Polymyxin B Sulfate API, Industry Ranking, 2023 VS 2024
3.4 Global Polymyxin B Sulfate API Sales Price by Manufacturers (2020-2025)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Polymyxin B Sulfate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Polymyxin B Sulfate API, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Polymyxin B Sulfate API, Product Offered and Application
3.8 Global Key Manufacturers of Polymyxin B Sulfate API, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Sales by Type
4.1.1 Global Polymyxin B Sulfate API Historical Sales by Type (2020-2025)
4.1.2 Global Polymyxin B Sulfate API Forecasted Sales by Type (2026-2031)
4.1.3 Global Polymyxin B Sulfate API Sales Market Share by Type (2020-2031)
4.2 Global Revenue by Type
4.2.1 Global Polymyxin B Sulfate API Historical Revenue by Type (2020-2025)
4.2.2 Global Polymyxin B Sulfate API Forecasted Revenue by Type (2026-2031)
4.2.3 Global Polymyxin B Sulfate API Revenue Market Share by Type (2020-2031)
4.3 Global Price by Type
4.3.1 Global Polymyxin B Sulfate API Price by Type (2020-2025)
4.3.2 Global Polymyxin B Sulfate API Price Forecast by Type (2026-2031)

5 Market Size by Application
5.1 Global Sales by Application
5.1.1 Global Polymyxin B Sulfate API Historical Sales by Application (2020-2025)
5.1.2 Global Polymyxin B Sulfate API Forecasted Sales by Application (2026-2031)
5.1.3 Global Polymyxin B Sulfate API Sales Market Share by Application (2020-2031)
5.2 Global Revenue by Application
5.2.1 Global Polymyxin B Sulfate API Historical Revenue by Application (2020-2025)
5.2.2 Global Polymyxin B Sulfate API Forecasted Revenue by Application (2026-2031)
5.2.3 Global Polymyxin B Sulfate API Revenue Market Share by Application (2020-2031)
5.3 Global Price by Application
5.3.1 Global Polymyxin B Sulfate API Price by Application (2020-2025)
5.3.2 Global Polymyxin B Sulfate API Price Forecast by Application (2026-2031)

6 US & Canada
6.1 US & Canada Market Size by Type
6.1.1 US & Canada Polymyxin B Sulfate API Sales by Type (2020-2031)
6.1.2 US & Canada Polymyxin B Sulfate API Revenue by Type (2020-2031)
6.2 US & Canada Market Size by Application
6.2.1 US & Canada Polymyxin B Sulfate API Sales by Application (2020-2031)
6.2.2 US & Canada Polymyxin B Sulfate API Revenue by Application (2020-2031)
6.3 US & Canada Market Size by Country
6.3.1 US & Canada Polymyxin B Sulfate API Revenue by Country: 2020 VS 2024 VS 2031
6.3.2 US & Canada Polymyxin B Sulfate API Revenue by Country (2020-2031)
6.3.3 US & Canada Polymyxin B Sulfate API Sales by Country (2020-2031)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Market Size by Type
7.1.1 Europe Polymyxin B Sulfate API Sales by Type (2020-2031)
7.1.2 Europe Polymyxin B Sulfate API Revenue by Type (2020-2031)
7.2 Europe Market Size by Application
7.2.1 Europe Polymyxin B Sulfate API Sales by Application (2020-2031)
7.2.2 Europe Polymyxin B Sulfate API Revenue by Application (2020-2031)
7.3 Europe Market Size by Country
7.3.1 Europe Polymyxin B Sulfate API Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 Europe Polymyxin B Sulfate API Sales by Country (2020-2031)
7.3.3 Europe Polymyxin B Sulfate API Revenue by Country (2020-2031)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Market Size by Type
8.1.1 China Polymyxin B Sulfate API Sales by Type (2020-2031)
8.1.2 China Polymyxin B Sulfate API Revenue by Type (2020-2031)
8.2 China Market Size by Application
8.2.1 China Polymyxin B Sulfate API Sales by Application (2020-2031)
8.2.2 China Polymyxin B Sulfate API Revenue by Application (2020-2031)

9 Asia (excluding China)
9.1 Asia Market Size by Type
9.1.1 Asia Polymyxin B Sulfate API Sales by Type (2020-2031)
9.1.2 Asia Polymyxin B Sulfate API Revenue by Type (2020-2031)
9.2 Asia Market Size by Application
9.2.1 Asia Polymyxin B Sulfate API Sales by Application (2020-2031)
9.2.2 Asia Polymyxin B Sulfate API Revenue by Application (2020-2031)
9.3 Asia Market Size by Region
9.3.1 Asia Polymyxin B Sulfate API Revenue by Region: 2020 VS 2024 VS 2031
9.3.2 Asia Polymyxin B Sulfate API Revenue by Region (2020-2031)
9.3.3 Asia Polymyxin B Sulfate API Sales by Region (2020-2031)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Market Size by Type
10.1.1 Middle East, Africa and Latin America Polymyxin B Sulfate API Sales by Type (2020-2031)
10.1.2 Middle East, Africa and Latin America Polymyxin B Sulfate API Revenue by Type (2020-2031)
10.2 Middle East, Africa and Latin America Market Size by Application
10.2.1 Middle East, Africa and Latin America Polymyxin B Sulfate API Sales by Application (2020-2031)
10.2.2 Middle East, Africa and Latin America Polymyxin B Sulfate API Revenue by Application (2020-2031)
10.3 Middle East, Africa and Latin America Market Size by Country
10.3.1 Middle East, Africa and Latin America Polymyxin B Sulfate API Revenue by Country: 2020 VS 2024 VS 2031
10.3.2 Middle East, Africa and Latin America Polymyxin B Sulfate API Revenue by Country (2020-2031)
10.3.3 Middle East, Africa and Latin America Polymyxin B Sulfate API Sales by Country (2020-2031)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Corporate Profile
11.1 Xellia Pharmaceuticals Aps
11.1.1 Xellia Pharmaceuticals Aps Company Information
11.1.2 Xellia Pharmaceuticals Aps Overview
11.1.3 Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.4 Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Xellia Pharmaceuticals Aps Recent Developments
11.2 Biotika As
11.2.1 Biotika As Company Information
11.2.2 Biotika As Overview
11.2.3 Biotika As Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.4 Biotika As Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biotika As Recent Developments
11.3 Medisca
11.3.1 Medisca Company Information
11.3.2 Medisca Overview
11.3.3 Medisca Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.4 Medisca Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medisca Recent Developments
11.4 Hangzhou Zhongmei Huadong Pharmaceutical
11.4.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
11.4.2 Hangzhou Zhongmei Huadong Pharmaceutical Overview
11.4.3 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.4 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
11.5 Alp Pharm
11.5.1 Alp Pharm Company Information
11.5.2 Alp Pharm Overview
11.5.3 Alp Pharm Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.4 Alp Pharm Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Alp Pharm Recent Developments
11.6 Yancheng Youhua Pharmaceutical And Chemical Technology
11.6.1 Yancheng Youhua Pharmaceutical And Chemical Technology Company Information
11.6.2 Yancheng Youhua Pharmaceutical And Chemical Technology Overview
11.6.3 Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.4 Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Yancheng Youhua Pharmaceutical And Chemical Technology Recent Developments
11.7 Shandong Luxi Pharmaceutical
11.7.1 Shandong Luxi Pharmaceutical Company Information
11.7.2 Shandong Luxi Pharmaceutical Overview
11.7.3 Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.4 Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shandong Luxi Pharmaceutical Recent Developments
11.8 Jiangxi Nuclear Industry Reyphon Bio-Chemical
11.8.1 Jiangxi Nuclear Industry Reyphon Bio-Chemical Company Information
11.8.2 Jiangxi Nuclear Industry Reyphon Bio-Chemical Overview
11.8.3 Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.4 Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Jiangxi Nuclear Industry Reyphon Bio-Chemical Recent Developments
11.9 North China Pharmaceutical Huasheng
11.9.1 North China Pharmaceutical Huasheng Company Information
11.9.2 North China Pharmaceutical Huasheng Overview
11.9.3 North China Pharmaceutical Huasheng Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.4 North China Pharmaceutical Huasheng Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 North China Pharmaceutical Huasheng Recent Developments
11.10 Ganzhou Ruizhi Pharmaceutical
11.10.1 Ganzhou Ruizhi Pharmaceutical Company Information
11.10.2 Ganzhou Ruizhi Pharmaceutical Overview
11.10.3 Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.4 Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ganzhou Ruizhi Pharmaceutical Recent Developments
11.11 ChemWerth
11.11.1 ChemWerth Company Information
11.11.2 ChemWerth Overview
11.11.3 ChemWerth Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.4 ChemWerth Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ChemWerth Recent Developments
11.12 LGM Pharma
11.12.1 LGM Pharma Company Information
11.12.2 LGM Pharma Overview
11.12.3 LGM Pharma Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.4 LGM Pharma Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 LGM Pharma Recent Developments
11.13 Rochem International
11.13.1 Rochem International Company Information
11.13.2 Rochem International Overview
11.13.3 Rochem International Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.4 Rochem International Polymyxin B Sulfate API Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Rochem International Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Polymyxin B Sulfate API Industry Chain Analysis
12.2 Polymyxin B Sulfate API Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polymyxin B Sulfate API Production Mode & Process
12.4 Polymyxin B Sulfate API Sales and Marketing
12.4.1 Polymyxin B Sulfate API Sales Channels
12.4.2 Polymyxin B Sulfate API Distributors
12.5 Polymyxin B Sulfate API Customers

13 Polymyxin B Sulfate API Market Dynamics
13.1 Polymyxin B Sulfate API Industry Trends
13.2 Polymyxin B Sulfate API Market Drivers
13.3 Polymyxin B Sulfate API Market Challenges
13.4 Polymyxin B Sulfate API Market Restraints

14 Key Findings in the Global Polymyxin B Sulfate API Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

biaoTi

表と図のリスト

List of Tables
 Table 1. Global Polymyxin B Sulfate API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Major Manufacturers of Purity ≥99%
 Table 3. Major Manufacturers of 95%≤purity≤99%
 Table 4. Global Polymyxin B Sulfate API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 5. Global Polymyxin B Sulfate API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 6. Global Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Revenue Market Share by Region (2020-2031)
 Table 8. Global Polymyxin B Sulfate API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 9. Global Polymyxin B Sulfate API Sales by Region (2020-2031) & (Tons)
 Table 10. Global Sales Market Share by Region (2020-2031)
 Table 11. Global Polymyxin B Sulfate API Sales by Manufacturers (2020-2025) & (Tons)
 Table 12. Global Polymyxin B Sulfate API Sales Share by Manufacturers (2020-2025)
 Table 13. Global Polymyxin B Sulfate API Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 14. Global Polymyxin B Sulfate API Revenue Market Share by Manufacturers (2020-2025)
 Table 15. Global Key Players of Polymyxin B Sulfate API, Industry Ranking, 2023 VS 2024 VS 2024
 Table 16. Polymyxin B Sulfate API Price by Manufacturers (2020-2025) & (US$/kg)
 Table 17. Global Polymyxin B Sulfate API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 18. Global Polymyxin B Sulfate API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymyxin B Sulfate API as of 2024)
 Table 19. Global Key Manufacturers of Polymyxin B Sulfate API, Manufacturing Base Distribution and Headquarters
 Table 20. Global Key Manufacturers of Polymyxin B Sulfate API, Product Offered and Application
 Table 21. Global Key Manufacturers of Polymyxin B Sulfate API, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Polymyxin B Sulfate API Sales by Type (2020-2025) & (Tons)
 Table 24. Global Polymyxin B Sulfate API Sales by Type (2026-2031) & (Tons)
 Table 25. Global Sales Share by Type (2020-2031)
 Table 26. Global Polymyxin B Sulfate API Revenue by Type (2020-2025) & (US$ Million)
 Table 27. Global Polymyxin B Sulfate API Revenue by Type (2026-2031) & (US$ Million)
 Table 28. Global Revenue Share by Type (2020-2031)
 Table 29. Polymyxin B Sulfate API Price by Type (2020-2025) & (US$/kg)
 Table 30. Global Polymyxin B Sulfate API Price Forecast by Type (2026-2031) & (US$/kg)
 Table 31. Global Polymyxin B Sulfate API Sales by Application (2020-2025) & (Tons)
 Table 32. Global Polymyxin B Sulfate API Sales by Application (2026-2031) & (Tons)
 Table 33. Global Sales Share by Application (2020-2031)
 Table 34. Global Polymyxin B Sulfate API Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Polymyxin B Sulfate API Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Revenue Share by Application (2020-2031)
 Table 37. Polymyxin B Sulfate API Price by Application (2020-2025) & (US$/kg)
 Table 38. Global Polymyxin B Sulfate API Price Forecast by Application (2026-2031) & (US$/kg)
 Table 39. US & Canada Sales by Type (2020-2031) & (Tons)
 Table 40. US & Canada Revenue by Type (2020-2031) & (US$ Million)
 Table 41. US & Canada Sales by Application (2020-2031) & (Tons)
 Table 42. US & Canada Revenue by Application (2020-2031) & (US$ Million)
 Table 43. US & Canada Polymyxin B Sulfate API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. US & Canada Revenue by Country (2020-2031) & (US$ Million)
 Table 45. US & Canada Sales by Country (2020-2031) & (Tons)
 Table 46. Europe Sales by Type (2020-2031) & (Tons)
 Table 47. Europe Revenue by Type (2020-2031) & (US$ Million)
 Table 48. Europe Sales by Application (2020-2031) & (Tons)
 Table 49. Europe Revenue by Application (2020-2031) & (US$ Million)
 Table 50. Europe Polymyxin B Sulfate API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 51. Europe Sales by Country (2020-2031) & (Tons)
 Table 52. Europe Revenue by Country (2020-2031) & (US$ Million)
 Table 53. China Sales by Type (2020-2031) & (Tons)
 Table 54. China Revenue by Type (2020-2031) & (US$ Million)
 Table 55. China Sales by Application (2020-2031) & (Tons)
 Table 56. China Revenue by Application (2020-2031) & (US$ Million)
 Table 57. Asia Sales by Type (2020-2031) & (Tons)
 Table 58. Asia Revenue by Type (2020-2031) & (US$ Million)
 Table 59. Asia Sales by Application (2020-2031) & (Tons)
 Table 60. Asia Revenue by Application (2020-2031) & (US$ Million)
 Table 61. Asia Polymyxin B Sulfate API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 62. Asia Revenue by Region (2020-2031) & (US$ Million)
 Table 63. Asia Sales by Region (2020-2031) & (Tons)
 Table 64. Middle East, Africa and Latin America Sales by Type (2020-2031) & (Tons)
 Table 65. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
 Table 66. Middle East, Africa and Latin America Sales by Application (2020-2031) & (Tons)
 Table 67. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
 Table 68. Middle East, Africa and Latin America Polymyxin B Sulfate API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 69. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
 Table 70. Middle East, Africa and Latin America Sales by Country (2020-2031) & (Tons)
 Table 71. Xellia Pharmaceuticals Aps Company Information
 Table 72. Xellia Pharmaceuticals Aps Description and Major Businesses
 Table 73. Xellia Pharmaceuticals Aps Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 74. Xellia Pharmaceuticals Aps Product Model Numbers, Pictures, Descriptions and Specifications
 Table 75. Xellia Pharmaceuticals Aps Recent Developments
 Table 76. Biotika As Company Information
 Table 77. Biotika As Description and Major Businesses
 Table 78. Biotika As Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 79. Biotika As Product Model Numbers, Pictures, Descriptions and Specifications
 Table 80. Biotika As Recent Developments
 Table 81. Medisca Company Information
 Table 82. Medisca Description and Major Businesses
 Table 83. Medisca Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 84. Medisca Product Model Numbers, Pictures, Descriptions and Specifications
 Table 85. Medisca Recent Developments
 Table 86. Hangzhou Zhongmei Huadong Pharmaceutical Company Information
 Table 87. Hangzhou Zhongmei Huadong Pharmaceutical Description and Major Businesses
 Table 88. Hangzhou Zhongmei Huadong Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 89. Hangzhou Zhongmei Huadong Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 90. Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
 Table 91. Alp Pharm Company Information
 Table 92. Alp Pharm Description and Major Businesses
 Table 93. Alp Pharm Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 94. Alp Pharm Product Model Numbers, Pictures, Descriptions and Specifications
 Table 95. Alp Pharm Recent Developments
 Table 96. Yancheng Youhua Pharmaceutical And Chemical Technology Company Information
 Table 97. Yancheng Youhua Pharmaceutical And Chemical Technology Description and Major Businesses
 Table 98. Yancheng Youhua Pharmaceutical And Chemical Technology Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 99. Yancheng Youhua Pharmaceutical And Chemical Technology Product Model Numbers, Pictures, Descriptions and Specifications
 Table 100. Yancheng Youhua Pharmaceutical And Chemical Technology Recent Developments
 Table 101. Shandong Luxi Pharmaceutical Company Information
 Table 102. Shandong Luxi Pharmaceutical Description and Major Businesses
 Table 103. Shandong Luxi Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 104. Shandong Luxi Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 105. Shandong Luxi Pharmaceutical Recent Developments
 Table 106. Jiangxi Nuclear Industry Reyphon Bio-Chemical Company Information
 Table 107. Jiangxi Nuclear Industry Reyphon Bio-Chemical Description and Major Businesses
 Table 108. Jiangxi Nuclear Industry Reyphon Bio-Chemical Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 109. Jiangxi Nuclear Industry Reyphon Bio-Chemical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 110. Jiangxi Nuclear Industry Reyphon Bio-Chemical Recent Developments
 Table 111. North China Pharmaceutical Huasheng Company Information
 Table 112. North China Pharmaceutical Huasheng Description and Major Businesses
 Table 113. North China Pharmaceutical Huasheng Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 114. North China Pharmaceutical Huasheng Product Model Numbers, Pictures, Descriptions and Specifications
 Table 115. North China Pharmaceutical Huasheng Recent Developments
 Table 116. Ganzhou Ruizhi Pharmaceutical Company Information
 Table 117. Ganzhou Ruizhi Pharmaceutical Description and Major Businesses
 Table 118. Ganzhou Ruizhi Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 119. Ganzhou Ruizhi Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 120. Ganzhou Ruizhi Pharmaceutical Recent Developments
 Table 121. ChemWerth Company Information
 Table 122. ChemWerth Description and Major Businesses
 Table 123. ChemWerth Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 124. ChemWerth Product Model Numbers, Pictures, Descriptions and Specifications
 Table 125. ChemWerth Recent Developments
 Table 126. LGM Pharma Company Information
 Table 127. LGM Pharma Description and Major Businesses
 Table 128. LGM Pharma Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 129. LGM Pharma Product Model Numbers, Pictures, Descriptions and Specifications
 Table 130. LGM Pharma Recent Developments
 Table 131. Rochem International Company Information
 Table 132. Rochem International Description and Major Businesses
 Table 133. Rochem International Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 134. Rochem International Product Model Numbers, Pictures, Descriptions and Specifications
 Table 135. Rochem International Recent Developments
 Table 136. Key Raw Materials Lists
 Table 137. Raw Materials Key Suppliers Lists
 Table 138. Distributors List
 Table 139. Customers List
 Table 140. Market Trends
 Table 141. Market Drivers
 Table 142. Market Challenges
 Table 143. Market Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources


List of Figures
 Figure 1. Polymyxin B Sulfate API Product Picture
 Figure 2. Global Polymyxin B Sulfate API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Polymyxin B Sulfate API Market Share by Type: 2024 & 2031
 Figure 4. Purity ≥99% Product Picture
 Figure 5. 95%≤purity≤99% Product Picture
 Figure 6. Global Polymyxin B Sulfate API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Global Polymyxin B Sulfate API Market Share by Application: 2024 & 2031
 Figure 8. Injection
 Figure 9. Others
 Figure 10. Polymyxin B Sulfate API Report Years Considered
 Figure 11. Global Polymyxin B Sulfate API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Polymyxin B Sulfate API Revenue by Region (2020-2031) (US$ Million)
 Figure 14. Global Polymyxin B Sulfate API Revenue Market Share by Region in Percentage: 2024 Versus 2031
 Figure 15. Global Polymyxin B Sulfate API Revenue Market Share by Region (2020-2031)
 Figure 16. Global Polymyxin B Sulfate API Sales (2020-2031) & (Tons)
 Figure 17. Global Polymyxin B Sulfate API Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 18. Global Polymyxin B Sulfate API Sales Market Share by Region (2020-2031)
 Figure 19. US & Canada Polymyxin B Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 20. US & Canada Polymyxin B Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 21. Europe Polymyxin B Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 22. Europe Polymyxin B Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. China Polymyxin B Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 24. China Polymyxin B Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. Asia (excluding China) Polymyxin B Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 26. Asia (excluding China) Polymyxin B Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Middle East, Africa and Latin America Polymyxin B Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 28. Middle East, Africa and Latin America Polymyxin B Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Global Polymyxin B Sulfate API Sales Share by Manufacturers (2024)
 Figure 30. The Polymyxin B Sulfate API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
 Figure 31. Global Polymyxin B Sulfate API Revenue Share by Manufacturers (2024)
 Figure 32. The Top 5 and 10 Largest Manufacturers of Polymyxin B Sulfate API in the World: Market Share by Polymyxin B Sulfate API Revenue in 2024
 Figure 33. Global Polymyxin B Sulfate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 34. Global Polymyxin B Sulfate API Sales Market Share by Type (2020-2031)
 Figure 35. Global Polymyxin B Sulfate API Revenue Market Share by Type (2020-2031)
 Figure 36. Global Polymyxin B Sulfate API Sales Market Share by Application (2020-2031)
 Figure 37. Global Polymyxin B Sulfate API Revenue Market Share by Application (2020-2031)
 Figure 38. US & Canada Polymyxin B Sulfate API Sales Market Share by Type (2020-2031)
 Figure 39. US & Canada Polymyxin B Sulfate API Revenue Market Share by Type (2020-2031)
 Figure 40. US & Canada Polymyxin B Sulfate API Sales Market Share by Application (2020-2031)
 Figure 41. US & Canada Polymyxin B Sulfate API Revenue Market Share by Application (2020-2031)
 Figure 42. US & Canada Polymyxin B Sulfate API Revenue Share by Country (2020-2031)
 Figure 43. US & Canada Polymyxin B Sulfate API Sales Share by Country (2020-2031)
 Figure 44. US Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 45. Canada Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 46. Europe Polymyxin B Sulfate API Sales Market Share by Type (2020-2031)
 Figure 47. Europe Polymyxin B Sulfate API Revenue Market Share by Type (2020-2031)
 Figure 48. Europe Polymyxin B Sulfate API Sales Market Share by Application (2020-2031)
 Figure 49. Europe Polymyxin B Sulfate API Revenue Market Share by Application (2020-2031)
 Figure 50. Europe Polymyxin B Sulfate API Sales Share by Country (2020-2031)
 Figure 51. Europe Polymyxin B Sulfate API Revenue Share by Country (2020-2031)
 Figure 52. Germany Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 53. France Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 54. U.K. Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 55. Italy Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 56. Russia Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 57. China Polymyxin B Sulfate API Sales Market Share by Type (2020-2031)
 Figure 58. China Polymyxin B Sulfate API Revenue Market Share by Type (2020-2031)
 Figure 59. China Polymyxin B Sulfate API Sales Market Share by Application (2020-2031)
 Figure 60. China Polymyxin B Sulfate API Revenue Market Share by Application (2020-2031)
 Figure 61. Asia Polymyxin B Sulfate API Sales Market Share by Type (2020-2031)
 Figure 62. Asia Polymyxin B Sulfate API Revenue Market Share by Type (2020-2031)
 Figure 63. Asia Polymyxin B Sulfate API Sales Market Share by Application (2020-2031)
 Figure 64. Asia Polymyxin B Sulfate API Revenue Market Share by Application (2020-2031)
 Figure 65. Asia Polymyxin B Sulfate API Revenue Share by Region (2020-2031)
 Figure 66. Asia Polymyxin B Sulfate API Sales Share by Region (2020-2031)
 Figure 67. Japan Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 68. South Korea Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 69. China Taiwan Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 70. Southeast Asia Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 71. India Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 72. Australia Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 73. Middle East, Africa and Latin America Polymyxin B Sulfate API Sales Market Share by Type (2020-2031)
 Figure 74. Middle East, Africa and Latin America Polymyxin B Sulfate API Revenue Market Share by Type (2020-2031)
 Figure 75. Middle East, Africa and Latin America Polymyxin B Sulfate API Sales Market Share by Application (2020-2031)
 Figure 76. Middle East, Africa and Latin America Polymyxin B Sulfate API Revenue Market Share by Application (2020-2031)
 Figure 77. Middle East, Africa and Latin America Polymyxin B Sulfate API Revenue Share by Country (2020-2031)
 Figure 78. Middle East, Africa and Latin America Polymyxin B Sulfate API Sales Share by Country (2020-2031)
 Figure 79. Brazil Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 80. Mexico Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 81. Turkey Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 82. Israel Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 83. GCC Countries Polymyxin B Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 84. Value Chain
 Figure 85. Polymyxin B Sulfate API Production Process
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)